ARCHIVES

FDA Oncologic Drugs Advisory Committee Okays THC For Group C List

This article is from The Cancer Letter archive.

Vol. 06 No. 27 | July 4, 1980

Download PDF Visit The Full Archive

Related Articles

UT Health System’s Probe Finds Lapses at MD Anderson, CPRIT—But No Nepotism

June 15, 2012

Drug Shortages: Institutions Report Halting Enrollment in Clinical Trials

March 22, 2013

In Brief: Lippman Leads M.D. Anderson Clinical Prevention; Baylin Named Ludwig Professor

May 10, 1996

Cancer Care Uneven, IOM’s National Cancer Policy Board Concludes

April 9, 1999

Women 80 And Older Benefit From Mammography

May 30, 2008

L.I. Center At Stony Brook’s Goal Is Comprehensive Status.

October 27, 2000